Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Unknown 5Recruiting 3Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Leiomyoma 2Myofibroma 1Menorrhagia 1Endometriosis 1Dysmenorrhea 1Blood Loss, Surgical 1Adenomyosis 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Uterine Myomectomy × Clear all
NCT06692335 2026-03-27

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

Chinese University of Hong Kong

Phase NA Recruiting
112 enrolled

Dysmenorrhea, Leiomyoma, Menorrhagia

NCT06882824 2025-09-24

HEMOMYOC

University Hospital, Clermont-Ferrand

Phase NA Recruiting
80 enrolled

Blood Loss, Surgical, Myofibroma

NCT06991595 2025-05-28

REAdME

Charles University, Czech Republic

Recruiting
236 enrolled

Endometriosis, Leiomyoma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡